Remove 2007 Remove Insurance Coverage and Processing Remove Labelling
article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

Coverage of Anti-Obesity Medications (AOMs) The NHC applauds CMS for aligning with the medical community and proposing to recognize obesity as a chronic disease and allow Medicare Part D coverage for AOMs. Below, we provide detailed comments and recommendations on key provisions of the proposed rule.

article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

Dr. Bernard Bihari is credited with making these discoveries about using naltrexone off-label, at lower doses. The first article was published in 2007, and it showed LDN as an effective and safe therapy for Crohn’s disease. [4] It’s a process and a journey, but it’s definitely worth it. LDN is truly an intriguing drug.